Search results
PROMOTED
How do worsening heart events dictate the long-term outcomes of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and can earlier intervention influence the disease trajectory in ATTR-CM? In this new sub-analysis from ATTRibute-CM, recorded onsite at ESC Heart Failure Congress (HFA) 2026, Prof Marianna Fontana (University College London, London, UK) sheds further light onto these…
View more
HFA 2026: Updates on ATTR-CM
Author(s):
Marianna Fontana
,
Added:
4 days ago
Video Series
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s):
Wei Gao
,
Hui Wang
,
Jian-long Wang
,
et al
Added:
6 months ago
Original Research
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
1 year ago
POTS-associated Conditions and Management Strategies
Video Series
Author(s):
Devi Nair
Added:
3 months ago
AF Symposium 2026 - Dr Devi Nair (St Bernards Heart & Vascular, US) joins us to discuss early outcomes from the VERITAS Study, evaluating Abbott's next-generation Amulet 360™ Left Atrial Appendage Occluder for stroke prevention in patients with non-valvular atrial fibrillation.This pivotal study enrolled 400 patients across 34 centers in the United States, Canada, and Europe. Findings presented…
View more
Author(s):
Milind Y Desai
Added:
1 year ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene…
View more
Author(s):
Rosana González Mesa
,
Aaron Álvarez Amigo
,
Alejandro Gullón de la Roza
,
et al
Added:
1 month ago
Author(s):
Julien Dreyfus
Added:
12 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating…
View more
Author(s):
Rick Veasey
Added:
1 year ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East…
View more
Author(s):
Larry Chinitz
Added:
1 year ago
HRS 24 - Dr Larry Chinitz (NYU School of Medicine, US) joins us to discuss the findings of the prospective, multicenter BIO-CONDUCT study, which investigated the safety and efficacy of the BIOTRONIK Solia S pacing lead implanted in the left bundle branch area (LBB) (NCT05251363, Biotronik Inc.). 186 patients with atrioventricular block, bradycardia, left bundle-branch block or cardiomyopathies…
View more